Augmentin Es Powder For Oral Suspension 600-42.9Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Augmentin ES: Powder for oral suspension (600-42.9mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


In-Depth Information
Select a Medication

Augmentin ES 600mg/5ml Powder for Suspension

NDC: 435980003
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Impetigo, Cystitis, Skin And Skin Structure Infections, Urinary Tract Infection (UTI), Otitis Media

Sometimes used for but not FDA approved for the following conditions:
Pneumonia, Febrile Neutropenia, Pericoronitis, Dental Infection, Dentoalveolar Infection, Sinusitis, Periodontitis, Lower Respiratory Tract Infections, Actinomycotic Mycetoma, Melioidosis, Community-acquired Pneumonia

Storage Information
Store reconstituted product in refrigerator (36 to 46 degrees F), discard after 10 days
Store in original container
Store unreconstituted product at or below 77 degrees F
Augmentin ES 600mg/5ml Powder for Suspension

Reported Side Effects for Augmentin ES 600mg/5ml Powder for Suspension

High Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
1.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0-8.0%*
Severity: MILD
Onset: EARLY
Vaginal Infection Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.1-3.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
3.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
4.0-34.3%*
Severity: MILD
Onset: EARLY
Diaper Rash Incidence:
5.0-6.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Augmentin ES

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5